local_hospital

Mental Health Center - Haskovo EOOD

Address
Str Blvd Saedinenie 22a, 6300 Haskovo, Bulgaria

Psychiatry and Psychology

At the Mental Health Center - Haskovo EOOD, clinical research in psychiatry focuses on schizophrenia, with studies aimed at understanding and improving the treatment of acute symptoms in hospitalized adults. The work is centered on evaluating how well new approaches may help reduce both positive and negative symptom burden.

  • Schizophrenia in adult inpatients
  • Assessment of treatment response for acute episodes
  • Testing a new therapy against placebo to measure symptom improvement

This area reflects the site’s role in advancing better care for serious mental disorders through research that may support more effective symptom control and improved patient outcomes.

Digestive System Diseases

Clinical trials in gastroenterology at this site address ulcerative colitis, with a focus on helping patients reach remission and maintain control of active disease. The research is designed to evaluate whether treatment can reduce inflammation and improve clinical signs of bowel disease.

  • Ulcerative colitis with mild to moderate active disease
  • Measuring clinical and endoscopic remission
  • Evaluating the effectiveness of an oral treatment for inducing remission

These studies highlight the site’s contribution to digestive system disease research, with an emphasis on improving treatment success and supporting better disease management for patients.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
1
IMP

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
1
Outperforms 0% of sites
public
Therapeutic diversity
1areas
Outperforms 0% of sites
groups
Sponsor diversity
1sponsors
Outperforms 0% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Mental Health Center - Haskovo EOOD

Trial Sponsor Phase Status Start Date End Date
A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GXV813 in Hospitalized Adults with SchizophreniaNovartis Pharma AGPhase IIRecruitingJun 2026

IMP list

IMP Trials Status First start Last start
GXV8131Unknown2026-06-222026-06-22

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.